Ingrid Bauer

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Technical University of Munich(Current)

University of Augsburg

Bezirkskrankenhaus Augsburg

Ludwig-Maximilians-Universität München

LMU Klinikum

Ingrid Bauer is an author at Technical University of Munich specializing in schizophrenia spectrum disorders, mineralocorticoid receptor antagonism, and spironolactone therapy.

Publications per year

2020–2023

Publications

Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial

Alkomiet Hasan, Astrid Roeh, Stefan Leucht et al. · Contemporary Clinical Trials Communications · 2020 · 22 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial

Elias Wagner, Wolfgang Strube, Thomas Görlitz et al. · Pharmacopsychiatry · 2023 · 12 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16

Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial

Wolfgang Strube, Aslihan Aksar, Ingrid Bauer et al. · Journal of Neural Transmission · 2022 · 10 citations · Full text

Medicine, Pharmacology, Psychiatry +17

1–3 of 3